Divis Laboratories Ltd | DIVI - Operating Expenses

Stock Price
6,361.50
Daily Change
-17.00 -0.27%
Monthly
5.77%
Yearly
5.80%
Q2 Forecast
6,090.72

Divis Laboratories Ltd reported INR18.32B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Alaunos Therapeutics USD 1.19M 148K Sep/2025
Aurobindo Pharma INR 73.37B 3.01B Dec/2025
Avita Medical AUD 28.02M 1.55M Dec/2025
Dianthus Therapeutics USD 69.82M 29.14M Dec/2025
Divis Laboratories Ltd INR 18.32B 1.08B Dec/2025
Ionis Pharmaceuticals USD 418M 101.1M Dec/2025
IQVIA Holdings USD 1.69B 4.47B Dec/2025
Lupin INR 52.71B 443.1M Dec/2025
Moderna USD 1.54B 259M Dec/2025
Organon & Co USD 906M 362M Sep/2025
Revvity USD 626.22M 25.62M Dec/2025
Tectonic Therapeutic USD 21.52M 374K Dec/2025
Tilray USD 237.52M 17.34M Sep/2025
Viatris USD 3.86B 335.7M Dec/2025
Xeris Pharmaceuticals USD 69.03M 1.38M Dec/2025